VentriPoint Diagnostics (VPTDF, $0.09) was a top loser over the last three months, falling -1 to $0.09 per share. A.I.dvisor analyzed 396 stocks in the Medical Specialties Industry for the 3-month period ending June 4, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.